MORRISVILLE, N.C.--(BUSINESS WIRE)--Aug. 30, 2006--BioDelivery Sciences International, Inc. (NASDAQ:BDSI), a specialty biopharmaceutical company focused on acute care products, including pain therapies, has appointed Thomas W. D’Alonzo to the company’s Board of Directors, effective today.
